Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. 1997

R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
Cancer Research Campaign Centre for Cell and Molecular Biology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom.

It has previously been shown that maximal activation of Raf-1 is produced by synergistic signals from oncogenic Ras and activated tyrosine kinases. This synergy arises because Ras-GTP translocates Raf-1 to the plasma membrane where it becomes phosphorylated on tyrosine residues 340 and 341 by membrane-bound tyrosine kinases (Marais, R., Light, Y., Paterson, H. F., and Marshall, C. J. (1995) EMBO J. 14, 3136-3145). We have examined whether the other two members of the Raf family, A-Raf and B-Raf, are regulated in a similar way to Raf-1. A-Raf behaves like Raf-1, being weakly activated by oncogenic Ras more strongly activated by oncogenic Src, and these signals synergize to give maximal activation. B-Raf by contrast is strongly activated by oncogenic Ras alone and is not activated by oncogenic Src. These results show that maximal activation of B-Raf merely requires signals that generate Ras-GTP, whereas activation of Raf-1 and A-Raf requires Ras-GTP together with signals that lead to their tyrosine phosphorylation. B-Raf may therefore be the primary target of oncogenic Ras.

UI MeSH Term Description Entries
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D015688 Oncogene Protein pp60(v-src) A tyrosine-specific protein kinase encoded by the v-src oncogene of ROUS SARCOMA VIRUS. The transforming activity of pp60(v-src) depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60(v-src) to the plasma membrane which is accomplished by myristylation of its N-terminal glycine. Oncogene Protein pp60(src),pp60(v-src),src Oncogene Protein pp60,v-src Protein pp60,Avian Sarcoma Virus-Transforming Protein,Oncogene Protein src,Phosphoprotein pp60(v-src),Rous Sarcoma Virus-Transforming Protein pp60(v-src),p60(v-src),pp60 v-src,src Oncogene Product pp60,v-src Protein,Avian Sarcoma Virus Transforming Protein,Protein pp60, v-src,Protein src, Oncogene,pp60 v src,pp60, v-src Protein,src, Oncogene Protein,v src Protein,v src Protein pp60,v-src, pp60
D015689 Oncogene Protein p21(ras) Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene (c-ras) can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21(ras) has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20% of all human tumors. This enzyme was formerly listed as EC 3.6.1.47. p21(v-Ha-ras),p21(v-Ki-ras),ras Oncogene Protein p21,p21 Transforming Viral Protein,p21 v-H-ras,p21 v-Ha-ras,p21 v-Ki-ras,p21 v-ras,p21(v-H-ras),p21(v-K-ras),ras Oncogene Product p21,ras Oncogene p21 Product,p21 v H ras,p21 v Ha ras,p21 v Ki ras,p21 v ras,v-H-ras, p21,v-Ha-ras, p21,v-Ki-ras, p21,v-ras, p21

Related Publications

R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
December 2020, International journal of molecular sciences,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
December 1994, Proceedings of the National Academy of Sciences of the United States of America,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
January 2006, Molecular psychiatry,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
February 2004, The Journal of clinical investigation,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
August 1995, Molecular and cellular biology,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
October 1995, Molecular and cellular biology,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
November 2005, Molecular endocrinology (Baltimore, Md.),
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
May 1994, Biochemical Society transactions,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
December 2004, Cellular and molecular life sciences : CMLS,
R Marais, and Y Light, and H F Paterson, and C S Mason, and C J Marshall
March 2000, Current biology : CB,
Copied contents to your clipboard!